A drug-eluting stent (DES) has been shown to be absorbed entirely after implantation into patients' blood vessels for the first time.
Abbott's bioabsorbable DES technology has been backed by further results of the ABSORB clinical trial, which reported on the first 30 patients two years after the stent was implanted. The study's investigators presented imaging data at the Transcatheter Cardiovascular Therapeutics (TCT) 2008 meeting, held in Washington, DC, last week, showing that the device disappeared completely.
Clinica, 20 October 2008
http://www.clinica.co.uk/marketsector/cardiovascular/Abbotts-bioabsorbable-DE...
This would have to be the "Key" for "Liberation Treatment" so that the Jugular Veins in CCSVI will not restenose again after the procedure is carried out.
Dr. Zamboni and Abbott Vascular are going to the Nobel Prize for the most critical advancement in medicine ever!
scifiak 1 year ago